• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

完整的HPV16 E6/E7基因表达在p53状态未改变且pRb细胞周期调控受到干扰的头颈癌中的作用。

Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.

作者信息

Wiest Tina, Schwarz Elisabeth, Enders Christel, Flechtenmacher Christa, Bosch Franz X

机构信息

Molekularbiologisches Labor, Universitäts-Hals-Nasen-Ohrenklinik, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.

出版信息

Oncogene. 2002 Feb 28;21(10):1510-7. doi: 10.1038/sj.onc.1205214.

DOI:10.1038/sj.onc.1205214
PMID:11896579
Abstract

We have identified parameters which define a causal role of HPV16 in head and neck cancer. Twenty-eight tumours which were typed positive for HPV16 DNA, were comprehensively analysed for expression of the viral oncogenes E6 and E7, the status of the p53 gene, and the protein status of pRb and p16(INK4a). In a subset of cases, we have searched for integrated viral DNA, and have determined the genomic status of the E6 gene. Expression of E6/E7 was found in 12 tumours most of which were derived from the oropharynx, whereas p53 mutations were present in 13 tumours from various sites. The tumours either carried p53 mutations but did not express E6/E7, or they did express E6/E7 but were p53-wild-type. Coexistence of E6/E7 expression with a mutated p53 was found in only one case. Strikingly, in most p53-mutated tumours without E6/E7 expression, we found the E6 gene to be disrupted. E6/E7 expression was associated with reduced pRb and overexpressed p16(INK4a). Viral-cellular fusion transcripts were found in two cases. Our data demonstrate that HPV16 DNA-positivity in head and neck cancers is not indicative of a causal role. A causal role of HPV16 in head and neck cancer is defined by: E6/E7 expression, viral integration with an intact E6 gene, and perturbation of pRb cell cycle control. Mostly, the p53 gene is wild-type.

摘要

我们已经确定了一些参数,这些参数定义了人乳头瘤病毒16型(HPV16)在头颈癌中的因果作用。对28例HPV16 DNA检测呈阳性的肿瘤进行了全面分析,检测病毒癌基因E6和E7的表达、p53基因状态以及视网膜母细胞瘤蛋白(pRb)和p16(INK4a)的蛋白状态。在部分病例中,我们寻找了整合的病毒DNA,并确定了E6基因的基因组状态。在12例肿瘤中发现了E6/E7的表达,其中大多数来源于口咽,而在来自不同部位的13例肿瘤中存在p53突变。这些肿瘤要么携带p53突变但不表达E6/E7,要么表达E6/E7但p53为野生型。仅在1例病例中发现E6/E7表达与p53突变共存。引人注目的是,在大多数无E6/E7表达的p53突变肿瘤中,我们发现E6基因被破坏。E6/E7表达与pRb减少和p16(INK4a)过表达相关。在2例病例中发现了病毒-细胞融合转录本。我们的数据表明,头颈癌中HPV16 DNA阳性并不意味着其具有因果作用。HPV16在头颈癌中的因果作用由以下因素定义:E6/E7表达、病毒整合且E6基因完整以及pRb细胞周期控制受到干扰。大多数情况下,p53基因为野生型。

相似文献

1
Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.完整的HPV16 E6/E7基因表达在p53状态未改变且pRb细胞周期调控受到干扰的头颈癌中的作用。
Oncogene. 2002 Feb 28;21(10):1510-7. doi: 10.1038/sj.onc.1205214.
2
Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas.头颈部癌中的人乳头瘤病毒16型E6和E7基因型
Oral Oncol. 2004 May;40(5):520-4. doi: 10.1016/j.oraloncology.2003.10.011.
3
E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.人乳头瘤病毒16型阳性口咽癌细胞的E6和E7基因沉默与转化表型
J Natl Cancer Inst. 2009 Mar 18;101(6):412-23. doi: 10.1093/jnci/djp017. Epub 2009 Mar 10.
4
RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.针对人乳头瘤病毒16型E7癌基因的RNA干扰通过上调Rb和p53导致宫颈癌细胞中的病毒E6和E7受到抑制并引发细胞凋亡。
Apoptosis. 2008 Feb;13(2):273-81. doi: 10.1007/s10495-007-0163-8.
5
Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.BPV1 E2介导的对HPV16阳性宫颈癌细胞中E6/E7表达的抑制作用。
Gynecol Oncol. 2001 Feb;80(2):168-75. doi: 10.1006/gyno.2000.6053.
6
The early HPV16 proteins can regulate mRNA levels of cell cycle genes in human cervical carcinoma cells by p53-independent mechanisms.早期人乳头瘤病毒16型蛋白可通过不依赖p53的机制调节人宫颈癌细胞中细胞周期基因的mRNA水平。
Virology. 1998 Apr 25;244(1):97-107. doi: 10.1006/viro.1998.9086.
7
Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7.由人乳头瘤病毒16型E6和E7永生化的人口腔上皮细胞中细胞周期调节蛋白的改变
Int J Oral Maxillofac Surg. 2006 Jul;35(7):653-7. doi: 10.1016/j.ijom.2006.01.017. Epub 2006 Feb 28.
8
Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control.致癌性人乳头瘤病毒在缺乏视网膜母细胞瘤细胞周期调控的扁桃体鳞状细胞癌中的病因学作用。
Cancer Res. 1998 Jan 1;58(1):5-13.
9
p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.p16/pRb信号通路改变是人类前列腺上皮细胞绕过衰老所必需的。
Cancer Res. 1999 Jun 15;59(12):2957-64.
10
Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells.在人乳头瘤病毒16型E6(而非E7)转化的人尿道上皮细胞中,衰老时p16升高,永生化时p16缺失。
Cancer Res. 1996 Jul 1;56(13):2886-90.

引用本文的文献

1
The TRIM22-CDT2 axis is the key mediator of the p53-Rb signals in growth control of HPV-positive cervical carcinoma cells.TRIM22-CDT2轴是p53-Rb信号在人乳头瘤病毒阳性宫颈癌细胞生长控制中的关键介质。
Neoplasia. 2025 Sep;67:101211. doi: 10.1016/j.neo.2025.101211. Epub 2025 Jul 17.
2
Human papillomavirus infection and screening strategies.人乳头瘤病毒感染与筛查策略
World J Clin Oncol. 2025 May 24;16(5):105055. doi: 10.5306/wjco.v16.i5.105055.
3
[Individualization and standardization in head and neck pathology].[头颈病理学中的个体化与标准化]
HNO. 2025 Apr 16. doi: 10.1007/s00106-025-01627-y.
4
HPV and p53 Status as Precision Determinants of Head and Neck Cancer Response to DNA-PKcs Inhibition in Combination with Irradiation.人乳头瘤病毒(HPV)和p53状态作为头颈部癌对DNA依赖蛋白激酶催化亚基(DNA-PKcs)抑制联合放疗反应的精准决定因素
Mol Cancer Ther. 2025 Feb 4;24(2):214-229. doi: 10.1158/1535-7163.MCT-23-0794.
5
Human Papillomaviruses 16 and 18 E6 Oncoprotein Detection Test in Primary Oropharyngeal Carcinomas and Metastatic Lymph Nodes: A Cross-Sectional Study.人乳头瘤病毒 16 型和 18 型 E6 癌蛋白检测在原发口咽癌及其转移淋巴结中的应用:一项横断面研究。
Head Neck Pathol. 2024 Oct 15;18(1):101. doi: 10.1007/s12105-024-01713-7.
6
Expression of Aberrant MicroRNAs and p16INK4a Associated with HPV (6, 11, 16, 18, 31, 33, 35, 42, 43, 44, 45, 52, 53, and 56) in Oral Dysplasia and Squamous Cell Carcinoma: A Retrospective Study.异常微 RNA 和 HPV(6、11、16、18、31、33、35、42、43、44、45、52、53 和 56)相关的 p16INK4a 在口腔发育异常和鳞状细胞癌中的表达:一项回顾性研究。
Turk Patoloji Derg. 2024;40(3):149-161. doi: 10.5146/tjpath.2024.12909.
7
Pathogenesis of Warthin's Tumor: Neoplastic or Non-Neoplastic?沃辛瘤的发病机制:肿瘤性还是非肿瘤性?
Cancers (Basel). 2024 Feb 23;16(5):912. doi: 10.3390/cancers16050912.
8
Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC.解析 HPV 介导的代谢调控在塑造肿瘤微环境中的作用及其对 HNSCC 免疫治疗的意义。
Front Immunol. 2023 Oct 9;14:1275270. doi: 10.3389/fimmu.2023.1275270. eCollection 2023.
9
[Research progress in diagnosis and treatment of HPV-associated oropharyngeal squamous cell carcinoma].[人乳头瘤病毒相关口咽鳞状细胞癌的诊断与治疗研究进展]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Sep;37(9):734-739. doi: 10.13201/j.issn.2096-7993.2023.09.009.
10
[Clinical characteristics and efficacy of oropharyngeal carcinoma with secondary primary tumor].[口咽癌伴发第二原发肿瘤的临床特征及疗效]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Sep;37(9):721-728. doi: 10.13201/j.issn.2096-7993.2023.09.007.